Organogenesis Reports the P-III Study Data of ReNu for Knee Osteoarthritis
Shots: Organogenesis reported data from the P-III study assessing the safety and e...
Boehringer Ingelheim Collaborates with Walgreens to Improve Clinical Trials Access
Shots: Boehringer Ingelheim has collaborated with Walgreens to enhance clinical tr...
Remix Therapeutics Reports First Patient Dosing in Two of REM-422’s P-I Studies for Treating ACC and AML or High-Risk MDS
Shots: Remix has recruited and dosed the first patient in two P-I dose escalation...
AstraZeneca Reports Data from the P-III (ECHO) Study of Calquence Combination Regimen for Mantle Cell Lymphoma
Shots: The P-III (ECHO) study investigates the safety & efficacy of Calquence...
Merck Reports the P-III (KEYNOTE-811) Study Data of Keytruda Plus Trastuzumab and Chemotherapy for G/GEJ Adenocarcinoma
Shots: The P-III (KEYNOTE-811) study assesses Keytruda + trastuzumab & CT vs P...
